 |
|
Risk of Mania With Antidepressants—Reply
Arch Pediatr Adolesc Med. 2005;159:298-299.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
We thank Drs Baldessarini, Hennen, and Faedda for their comments and careful reading of our article.1 We agree that as yet unrecognized or latent bipolar disorder is a particular concern and diagnostic challenge among young patients. Given this, and the age-dependent induction potential that we describe (suggesting that treatment with a selective serotonin reuptake inhibitor in as few as 11 to 15 children younger than 15 years is needed for 1 of them to experience a manic conversion, a level of risk that holds even after limiting our sample to patients with minor depression or an anxiety disorder), careful assessment and clinical monitoring during antidepressant treatment cannot be overemphasized—especially among children and adolescents.
As described in the "Methods" section of our article, we excluded from analysis those individuals who converted during the first 2 months of observation. Although we did this is an effort to minimize "misclassification errors, . . . [Full Text of this Article] AUTHOR INFORMATION
Andrés Martin, MD, MPH;
Christopher Young, MD;
James F. Leckman, MD;
Chengeto Mukonoweshuro, MD, MPH;
Robert Rosenheck, MD;
Douglas Leslie, PhD
RELATED ARTICLE
Risk of Mania With Antidepressants
Ross J. Baldessarini, Gianni L. Faedda, and John Hennen
Arch Pediatr Adolesc Med. 2005;159(3):298.
EXTRACT
| FULL TEXT
|
